CBCT evaluation of temporomandibular joint changes in patients with oral submucous fibrosis. [PDF]
Kumar S +5 more
europepmc +1 more source
<i>AKT3</i> and α-SMA in oral submucous fibrosis and oral squamous cell carcinoma with concomitant oral submucous fibrosis as potential prognostic indicators. [PDF]
Behera S +5 more
europepmc +1 more source
A systematic review and network meta-analysis of single nucleotide polymorphisms associated with oral submucous fibrosis risk. [PDF]
Huang C +7 more
europepmc +1 more source
A Multifunctional Nucleic Acid Nanomedicine Coregulates Angiogenesis and Fibrosis to Treat Oral Submucous Fibrosis. [PDF]
Fu X +7 more
europepmc +1 more source
Effectiveness of stem cells and platelet rich plasma in the treatment of oral submucous fibrosis. [PDF]
Bora SP +5 more
europepmc +1 more source
Silybin Derivative B1 Inhibits Myofibroblast Activation via Wnt/DAAM2 and Ameliorates Oral Submucous Fibrosis in Mice. [PDF]
Zhou J +9 more
europepmc +1 more source
Comparative evaluation of intralesional platelet-rich plasma and triamcinolone in management of oral submucous fibrosis: A prospective clinical study. [PDF]
Ughade V +4 more
europepmc +1 more source
Hypoxia and angiogenesis across clinical stages of oral submucous fibrosis: implications for oral carcinogenesis. [PDF]
Alka H +5 more
europepmc +1 more source
Comparative evaluation of salivary oxidative stress markers in oral leukoplakia and oral submucous fibrosis: A cross-sectional study. [PDF]
Chatterjee A +5 more
europepmc +1 more source

